AGA/AASLD joint guideline evaluates newer medications for primary biliary cholangitis
For the first time, a joint guideline from the American Gastroenterological Association (AGA) and American Association for the Study of Liver Diseases (AASLD) evaluates newer medications for primary biliary cholangitis (PBC), the most common cholestatic disease in adults.
Read original article on The Medical News →Related news
-
Modulating GPCR signaling could help delay multiple age-related diseases
United Kingdom
-
Why using AI saves doctors time but won't fix physician burnout
United Kingdom
-
Lab study shows needle-free mRNA vaccine protects against COVID and flu
United Kingdom
-
Obesity impairs key immune cells but bariatric surgery reverses damage
United Kingdom
-
New survey reveals how chronic stress impacts U.S. adults
United Kingdom
-
Napoleon can be partly blamed for Gen Z's weightlifting obsession—here's why
United Kingdom
-
Human neural stem cells found to be susceptible to SARS-CoV-2 variants
United Kingdom
-
New medical adhesive patch sticks securely but detaches with ease
United Kingdom